Business Wire

AIT Worldwide Logistics debuts new global headquarters in Chicago suburbs

14.8.2023 18:03:00 EEST | Business Wire | Press release

Share

Corporate teammates for supply chain solutions leader AIT Worldwide Logistics recently moved into a new global headquarters at 2 Pierce Place in Itasca, Illinois. Previously, AIT’s shared services teams were based out of multiple Itasca facilities, including 701 Rohlwing Rd., a single-story building and warehouse that had been shared with the company’s Chicago station since 1997.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230814443050/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

AIT’s new global headquarters occupies multiple floors of the iconic 25-story suburban tower at 2 Pierce Place in Itasca, Illinois. (Photo: Business Wire)

According to AIT’s Chairman and CEO, Vaughn Moore, the move was spurred by the organization’s exponential growth and emergence as a global logistics powerhouse.

“After more than 40 years in business, and immense expansion to more than 110 locations across Asia, Europe and North America, we’re fortifying our roots in the Chicago area,” Moore said. “This modern, highly visible location is a true manifestation of our global brand, and it provides our corporate staff with both the space and resources they need to best support our customers and teammates around the world.”

Moore added that the new location is a major investment in AIT teammates’ on-site work experience.

“Working together in this state-of-the-art office space allows us to be much more collaborative, enabling faster, real-time reactions,” he said. “2 Pierce Place also provides the additional space we need to accommodate the future growth of our shared services teams.”

AIT’s global headquarters occupies multiple floors of the iconic 25-story suburban tower. Standing at 395 feet, it is the second-tallest building in Illinois outside the Chicago city limits. From its modern lobby to the tenant lounge, game room and outdoor patio, 2 Pierce Place offers popular on-site amenities, including a fitness center, walking trail, a full-service deli serving breakfast and lunch, grab-and-go dining options, and on-site catering services.

Team members from accounting, claims, finance, global business systems, global compliance, human resources, imaging, information technology, legal and marketing are stationed on newly remodeled high-rise floors with conveniences including a private game room, coffee bars, sit-stand workstations, and multiple conference rooms equipped with state-of-the-art audio-visual capabilities.

In the coming months, the remaining Chicago area AIT teams in Itasca and Wood Dale (including dedicated food logistics and life sciences locations) are planning to move into a unified multi-service facility in the nearby suburb of Palatine. This new joint office and warehouse space is under construction. Meanwhile, AIT Truckload Solutions will continue to serve customers out of their current location at 55 W. Monroe St. in Chicago.

Conveniently located near the intersection of Interstate 290 and the Elgin-O’Hare Expressway, AIT’s new global headquarters is easily accessible from O’Hare International Airport:

AIT Worldwide Logistics

2 Pierce Place, Suite 2100

Itasca, IL 60143

Tel: +1 (630) 766-8300

Learn more about 2 Pierce Place at twopierceplace.com.

About AIT Worldwide Logistics

AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, food, government, healthcare, high-tech, industrial and life sciences. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes door-to-door deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 100 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.

Our Mission

At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Matt Sanders
Public Relations Manager
+1 (630) 766-8300
msanders@aitworldwide.com

AIT Worldwide Logistics, Inc.
Corporate Headquarters
701 N. Rohlwing Road
Itasca, IL 60143

800-669-4AIT (4248)
www.aitworldwide.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release

Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release

Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye